| Grade | Supplement | Main use | Score | Mechanistic | Animal | Human observational | Human RCT | Meta-analysis | Cost per day |
|---|
| AA Multiple randomized trials or meta-analyses, consistent results. How we grade → | Creatine monohydrate Foundation | Muscle strength and lean mass, with resistance training | 22/25 | | | | | | $0.56 |
| BB Good human data, but mixed outcomes or surrogate markers. How we grade → | Omega-3 (EPA and DHA) Foundation | Overall omega-3 evidence (claim rows: EPA and DHA status A, triglycerides B) | 19/25 | | | | | | $0.50 |
| DD Mostly mechanistic or early data. Shown openly. How we grade → | Vitamin D3 (in the multivitamin) Foundation | Bone health and normal immune function when your level is low (two claim rows, both D) | 17/25 | | | | | | $1.10 |
| CC Small or few human trials. Promising, not proven. How we grade → | Daily multivitamin Foundation | Filling common nutrient gaps | 17/25 | | | | | | $1.10 |
| CC Small or few human trials. Promising, not proven. How we grade → | Magnesium glycinate Foundation | Relaxation and sleep quality | 14/25 | | | | | | $0.90 |
| AA Multiple randomized trials or meta-analyses, consistent results. How we grade → | Whey protein Whey Protein Isolate, Vanilla (add-on) | Reaching daily protein for muscle, with training | 20/25 | | | | | | $2.14 |
| CC Small or few human trials. Promising, not proven. How we grade → | Electrolytes Performance add-on | Hydration on long or hot training days | 12/25 | | | | | | $1.30 |
| CC Small or few human trials. Promising, not proven. How we grade → | L-theanine Sleep add-on | Feeling calm and self-rated sleep | 14/25 | | | | | | $0.97 |
| CC Small or few human trials. Promising, not proven. How we grade → | Glycine Sleep add-on | Sleep quality | 12/25 | | | | | | $0.97 |
| CC Small or few human trials. Promising, not proven. How we grade → | Berberine HCl Metabolic add-on | Healthy glucose metabolism | 14/25 | | | | | | $0.97 |
| BB Good human data, but mixed outcomes or surrogate markers. How we grade → | Nicotinamide riboside (NR) NR add-on | Raising blood NAD+ | 12/25 | | | | | | $1.17 |
| CC Small or few human trials. Promising, not proven. How we grade → | Quercetin Phytosome Single product (optional) | Healthy inflammatory response | 9/25 | | | | | | $1.53 |
| BB Good human data, but mixed outcomes or surrogate markers. How we grade → | Vitamin D3 2,000 IU (status) Single product | Maintaining vitamin D status (blood 25(OH)D) in adults with low sun exposure or low intake | 20/25 | | | | | | $0.20 |
| CC Small or few human trials. Promising, not proven. How we grade → | Collagen Peptides Single product | Skin structure and hydration; joint comfort | 13/25 | | | | | | $2.14 |
| CC Small or few human trials. Promising, not proven. How we grade → | Magnesium L-threonate Reviewed, not in a box | Sleep and cognition | 10/25 | | | | | | Not sold |
| DD Mostly mechanistic or early data. Shown openly. How we grade → | Apigenin Reviewed, not in a box | Sleep and calm | 7/25 | | | | | | Not sold |
| CC Small or few human trials. Promising, not proven. How we grade → | NMN Reviewed, not sold | Raising NAD+ and insulin sensitivity | 9/25 | | | | | | Not sold |
| DD Mostly mechanistic or early data. Shown openly. How we grade → | Keto BHB salts Removed from the storefront | Brain energy and cognition | 8/25 | | | | | | Not sold |
Matrix: none, weak, moderate or compelling (0 to 3 squares). Cost per day is for each product bought on its own; Foundation has all four in one $69 box: 30 days of all four; the creatine and omega-3 last about 50 days each.
AA Multiple randomized trials or meta-analyses, consistent results. How we grade →Creatine monohydrate
Foundation · Muscle strength and lean mass, with resistance training
Sub-scores (22/25)
| Human RCTs | 5/5 |
| Effect size | 4/5 |
| Consistency | 5/5 |
| Safety | 5/5 |
| Independence | 3/5 |
Evidence matrix
| Mechanistic | Compelling |
| Animal | Compelling |
| Human observational | Weak |
| Human RCT | Compelling |
| Meta-analysis | Compelling |
What it is good for: Supporting strength and muscle with training, including in adults over 50.*
What it is not: It does not replace training, and brain or longevity uses are still early.
Cost per day: $0.56. Creatine Monohydrate on its own: $27.90 for 50 days. Part of Foundation: all four in one $69 box (founding price), 30 days of all four; the creatine and omega-3 last about 50 days each
Worth your money? Yes, if you train. The best-supported ingredient we sell.
Read the full evidence · Chilibeck 2017, Open Access J Sports Med (meta-analysis, 22 RCTs, 721 older adults) · Lanhers 2017, Sports Med (meta-analysis, 53 RCTs, upper body strength) · Naddafha 2026, J Int Soc Sports Nutr (meta-analysis, postmenopausal women) · Tsiaras 2026, J Ren Nutr (meta-analysis, kidney function) · Lak 2025, J Int Soc Sports Nutr (12-week RCT, hair and DHT) · Kreider 2017, J Int Soc Sports Nutr (ISSN position stand) · Candow 2014, Res Sports Med (RCT, 22 older adults, before vs after training) · Forbes 2021, J Sports Med Phys Fitness (within-subject trial, 10 young adults, timing)
BB Good human data, but mixed outcomes or surrogate markers. How we grade →Omega-3 (EPA and DHA)
Foundation · Overall omega-3 evidence (claim rows: EPA and DHA status A, triglycerides B)
Sub-scores (19/25)
| Human RCTs | 5/5 |
| Effect size | 3/5 |
| Consistency | 3/5 |
| Safety | 4/5 |
| Independence | 4/5 |
Why a B next to an A claim row: this 19/25 rates the whole evidence profile, mostly triglyceride and heart trials, not the separate EPA and DHA status claim. The two largest trials at 1 g a day in people without heart disease (VITAL, ASCEND) were flat on their main outcomes, and the triglyceride trials cited for the B triglyceride grade used about 4 g a day, far above a 600 mg serving. Raising EPA and DHA in red blood cells (the Omega-3 Index) on its own is graded A on our claims page; the rise depends on dose, and the pooled trials averaged about 2 g a day, more than a 600 mg serving.
Evidence matrix
| Mechanistic | Compelling |
| Animal | Moderate |
| Human observational | Moderate |
| Human RCT | Compelling |
| Meta-analysis | Compelling |
What it is good for: Raising EPA and DHA status.*
What it is not: Heart event results are mixed across large trials; our dose is far below the 4 g used in REDUCE-IT, and doses above 1 g a day were linked to more atrial fibrillation.
Cost per day: $0.50. Omega-3 Fish Oil on its own: $24.90 for 50 days. Part of Foundation: all four in one $69 box (founding price), 30 days of all four; the creatine and omega-3 last about 50 days each
Worth your money? Yes if you eat little oily fish. Eating fish twice a week does much of the same job.
Read the full evidence · Skulas-Ray 2019, Circulation (AHA advisory) · Bhatt 2019 (REDUCE-IT), NEJM · Manson 2019 (VITAL omega-3 arm, 25,871 adults, 1 g a day), NEJM · ASCEND 2018 (15,480 adults with diabetes, 1 g a day), NEJM · Aung 2018, JAMA Cardiol (meta-analysis, 10 trials, 77,917 people) · Gencer 2021, Circulation (atrial fibrillation) · NIH Office of Dietary Supplements, Omega-3 Fatty Acids fact sheet
DD Mostly mechanistic or early data. Shown openly. How we grade →Vitamin D3 (in the multivitamin)
Foundation · Bone health and normal immune function when your level is low (two claim rows, both D)
Sub-scores (17/25)
| Human RCTs | 5/5 |
| Effect size | 0/5 |
| Consistency | 3/5 |
| Safety | 4/5 |
| Independence | 5/5 |
Why a D next to a total of 17/25: the total is an evidence profile, not a measure of benefit, and this D is not the grade key's mostly mechanistic or early data. Human RCTs 5 of 5 means many large, independently funded trials, not that they found a benefit, and safety 4 of 5 rates risk at the label dose. Effect size is 0 of 5 because a reliable benefit for these label uses is not established. Respiratory infection trials did not show significant protection in people starting low, and they did not assess normal immune function as a whole. Exploratory or secondary analyses found bone density benefits in some people starting very low, but fewer fractures have not been shown. Both label uses are tagged Insufficient human evidence, and 0 of 5 does not mean every trial found zero effect. The matrix marks human trials and meta-analyses Compelling because that research is extensive, not because it shows a benefit for these label uses. Much of it concerns broader populations or respiratory infections rather than these exact claims in people starting low, and it does not establish a reliable benefit for these uses.
Evidence matrix
| Mechanistic | Compelling |
| Animal | Moderate |
| Human observational | Compelling |
| Human RCT | Compelling |
| Meta-analysis | Compelling |
What it is good for: Provides 400 IU (10 mcg) of vitamin D3 per 2 capsules, adding to vitamin D intake, which is low from food alone for most people in the US. The latest respiratory-infection review found no significant protection, including in people starting low.
What it is not: In people who already have enough, the largest trials were mostly flat. Routine testing is not suggested for generally healthy adults, including those with darker skin or obesity; ask your clinician if you have a medical reason.
Cost per day: $1.10. In the Complete Multivitamin, bought on its own: $32.90 for 30 days. Part of Foundation: all four in one $69 box (founding price), 30 days of all four; the creatine and omega-3 last about 50 days each
Worth your money? Optional. 400 IU adds to your vitamin D intake from food. Some exploratory or secondary analyses suggest bone density benefits at very low starting levels, but fewer fractures have not been shown. Protection from respiratory infections has not been shown in people starting low, and those trials did not assess normal immune function as a whole.
Read the full evidence · Martineau 2017, BMJ · Jolliffe 2021, Lancet Diabetes Endocrinol (updated meta-analysis, 37 trials in the main result) · Jolliffe 2025, Lancet Diabetes Endocrinol (2025 update, no significant protection) · Manson 2019 (VITAL), NEJM · LeBoff 2022 (VITAL fractures), NEJM · Demay 2024, J Clin Endocrinol Metab (Endocrine Society guideline) · Burt 2019 (high-dose trial), JAMA
CC Small or few human trials. Promising, not proven. How we grade →Daily multivitamin
Foundation · Filling common nutrient gaps
Sub-scores (17/25)
| Human RCTs | 4/5 |
| Effect size | 2/5 |
| Consistency | 2/5 |
| Safety | 5/5 |
| Independence | 4/5 |
Evidence matrix
| Mechanistic | Moderate |
| Animal | Weak |
| Human observational | Moderate |
| Human RCT | Compelling |
| Meta-analysis | Moderate |
What it is good for: Covering gaps in diets that fall short.*
What it is not: Large trials show no clear effect on heart disease or lifespan.
Cost per day: $1.10. Complete Multivitamin on its own: $32.90 for 30 days. Part of Foundation: all four in one $69 box (founding price), 30 days of all four; the creatine and omega-3 last about 50 days each
Worth your money? Cheap insurance for an imperfect diet, not a longevity tool.
Read the full evidence · Gaziano 2012 (PHS II), JAMA · Sesso 2012 (PHS II, heart attacks and strokes unchanged), JAMA · Sesso 2022 (COSMOS, 21,442 adults, no significant effect on major cardiovascular events), Am J Clin Nutr · Baker 2023 (COSMOS-Mind, 2,262 adults), Alzheimers Dement · Vyas 2024 (COSMOS cognition, pooled), Am J Clin Nutr · Loftfield 2024 (3 cohorts, 390,124 adults, no longer life), JAMA Netw Open · US Preventive Services Task Force 2022, JAMA
CC Small or few human trials. Promising, not proven. How we grade →Magnesium glycinate
Foundation · Relaxation and sleep quality
Sub-scores (14/25)
| Human RCTs | 2/5 |
| Effect size | 2/5 |
| Consistency | 2/5 |
| Safety | 5/5 |
| Independence | 3/5 |
Evidence matrix
| Mechanistic | Moderate |
| Animal | Moderate |
| Human observational | Moderate |
| Human RCT | Weak |
| Meta-analysis | Weak |
What it is good for: Supporting muscle relaxation and a calm wind-down.*
What it is not: Sleep trials are few and small; it is not a sleep treatment.
Cost per day: $0.90. Magnesium Glycinate on its own: $26.90 for 30 days. Part of Foundation: all four in one $69 box (founding price), 30 days of all four; the creatine and omega-3 last about 50 days each
Worth your money? Reasonable and very safe, with modest expected effects.
Read the full evidence · Schuster 2025, Nat Sci Sleep (bisglycinate RCT) · Mah 2021, BMC Complement Med Ther (meta-analysis) · Boyle 2017, Nutrients (systematic review, anxiety and stress) · NIH Office of Dietary Supplements, magnesium fact sheet (upper limit 350 mg a day from supplements)
AA Multiple randomized trials or meta-analyses, consistent results. How we grade →Whey protein
Whey Protein Isolate, Vanilla (add-on) · Reaching daily protein for muscle, with training
Sub-scores (20/25)
| Human RCTs | 5/5 |
| Effect size | 3/5 |
| Consistency | 4/5 |
| Safety | 5/5 |
| Independence | 3/5 |
Evidence matrix
| Mechanistic | Compelling |
| Animal | Moderate |
| Human observational | Moderate |
| Human RCT | Compelling |
| Meta-analysis | Compelling |
What it is good for: Convenient protein to support muscle with training.*
What it is not: No advantage over food protein if you already eat enough.
Cost per day: $2.14. $59.90 for 28 scoops (1 a day), add-on only: sold with another order, never alone
Worth your money? Yes if you struggle to hit protein; skip it if food covers you.
Read the full evidence · Morton 2018, Br J Sports Med · Nunes 2022, J Cachexia Sarcopenia Muscle (meta-analysis, 74 RCTs) · Mertz 2021 (CALM, 1-year RCT, protein alone vs with training), Am J Clin Nutr · Jäger 2017, J Int Soc Sports Nutr (ISSN position stand)
CC Small or few human trials. Promising, not proven. How we grade →Electrolytes
Performance add-on · Hydration on long or hot training days
Sub-scores (12/25)
| Human RCTs | 2/5 |
| Effect size | 2/5 |
| Consistency | 2/5 |
| Safety | 4/5 |
| Independence | 2/5 |
Evidence matrix
| Mechanistic | Compelling |
| Animal | Weak |
| Human observational | Weak |
| Human RCT | Weak |
| Meta-analysis | Weak |
What it is good for: Replacing sodium lost in heavy sweat.*
What it is not: Not needed for everyday activity; water is enough.
Cost per day: $1.30. Performance add-on, $39 for 30 days, shared with whey
Worth your money? Only for heavy sweaters and long sessions.
Read the full evidence · Sawka 2007, Med Sci Sports Exerc (ACSM position stand) · McDermott 2017, J Athl Train (NATA position statement) · Del Coso 2016, Scand J Med Sci Sports (salt capsule RCT, half-ironman) · Hoffman 2015, Med Sci Sports Exerc (observational, 161-km race) · Hew-Butler 2015, Clin J Sport Med (exercise-associated hyponatremia consensus) · Maughan 2016, Am J Clin Nutr (beverage hydration index, at rest)
CC Small or few human trials. Promising, not proven. How we grade →L-theanine
Sleep add-on · Feeling calm and self-rated sleep
Sub-scores (14/25)
| Human RCTs | 2/5 |
| Effect size | 2/5 |
| Consistency | 3/5 |
| Safety | 5/5 |
| Independence | 2/5 |
Evidence matrix
| Mechanistic | Moderate |
| Animal | Moderate |
| Human observational | None |
| Human RCT | Moderate |
| Meta-analysis | Weak |
What it is good for: Supporting relaxation and occasional stress.*
What it is not: Not for anxiety disorders; several trials were industry funded.
Cost per day: $0.97. Sleep add-on, $29 for 30 days, shared with glycine
Worth your money? Optional. Try it for a month and keep it only if you notice a difference.
Read the full evidence · Bulman 2025, Sleep Med Rev (meta-analysis, sleep) · Gerolymos 2026, Mol Psychiatry (meta-analysis, 31 RCTs) · Hidese 2019, Nutrients (4-week RCT; Taiyo-funded) · Williams 2020, Plant Foods Hum Nutr (systematic review, stress and anxiety) · Sarris 2019, J Psychiatr Res (GAD RCT, anxiety primary null) · Kimura 2007, Biol Psychol (acute stress RCT)
CC Small or few human trials. Promising, not proven. How we grade →Glycine
Sleep add-on · Sleep quality
Sub-scores (12/25)
| Human RCTs | 1/5 |
| Effect size | 2/5 |
| Consistency | 2/5 |
| Safety | 5/5 |
| Independence | 2/5 |
Evidence matrix
| Mechanistic | Moderate |
| Animal | Moderate |
| Human observational | None |
| Human RCT | Weak |
| Meta-analysis | None |
What it is good for: Supporting restful sleep.*
What it is not: Human trials are very small and short.
Cost per day: $0.97. Sleep add-on, $29 for 30 days, shared with L-theanine
Worth your money? Optional and inexpensive; evidence is thin.
Read the full evidence · Inagawa 2006, Sleep Biol Rhythms (19 women) · Yamadera 2007, Sleep Biol Rhythms · Bannai 2012, Front Neurol · Kawai 2015, Neuropsychopharmacology (rats; how glycine may act on sleep) · Soh 2024, Geroscience (systematic review; sleep evidence small, high risk of bias)
CC Small or few human trials. Promising, not proven. How we grade →Berberine HCl
Metabolic add-on · Healthy glucose metabolism
Sub-scores (14/25)
| Human RCTs | 3/5 |
| Effect size | 3/5 |
| Consistency | 3/5 |
| Safety | 2/5 |
| Independence | 3/5 |
Evidence matrix
| Mechanistic | Moderate |
| Animal | Compelling |
| Human observational | None |
| Human RCT | Moderate |
| Meta-analysis | Moderate |
What it is good for: Supporting healthy glucose metabolism already within normal range.*
What it is not: Not a diabetes treatment. Many trials are small and low quality, and it interacts with several drugs, including cyclosporine and medicines cleared by CYP3A4, CYP2D6 or CYP2C9.
Cost per day: $0.97. Metabolic add-on, $29 for 30 days
Worth your money? Maybe, after talking to your clinician, especially if you take medication.
Read the full evidence · Zhang 2020 (PREMOTE), Nat Commun (409-person placebo RCT) · Zhao 2023, J Nutr (meta-analysis, placebo-controlled trials) · Xie 2022, Front Pharmacol (meta-analysis, GRADE) · Lan 2015, J Ethnopharmacol (meta-analysis) · Wu 2005, Eur J Clin Pharmacol (cyclosporine interaction) · Guo 2012, Eur J Clin Pharmacol (CYP2D6, 2C9 and 3A4 slowed in healthy men) · Chen 2020, Lancet Gastroenterol Hepatol (1,108 adults, up to 2 years, safety)
BB Good human data, but mixed outcomes or surrogate markers. How we grade →Nicotinamide riboside (NR)
NR add-on · Raising blood NAD+
Sub-scores (12/25)
| Human RCTs | 3/5 |
| Effect size | 1/5 |
| Consistency | 3/5 |
| Safety | 3/5 |
| Independence | 2/5 |
Evidence matrix
| Mechanistic | Compelling |
| Animal | Compelling |
| Human observational | None |
| Human RCT | Moderate |
| Meta-analysis | Weak |
What it is good for: Supporting cellular NAD+ levels.*
What it is not: Raising NAD+ has not been shown to slow aging or improve function in people. In a year-long trial in early Parkinson disease, scores were slightly worse with NR than placebo, so skip it if you have Parkinson disease unless your neurologist agrees.
Cost per day: $1.17. NR add-on, $35 for 30 days
Worth your money? Only if you accept that the benefit is unproven.
Read the full evidence · Martens 2018, Nat Commun (raises blood NAD+) · Dollerup 2018, Am J Clin Nutr (obesity RCT; insulin sensitivity null) · Prokopidis 2025, J Cachexia Sarcopenia Muscle (meta-analysis, muscle null) · McDermott 2024, Nat Commun (PAD walk, one positive signal) · Brakedal 2026 (NOPARK), JAMA (early Parkinson phase 3; scores slightly worse vs placebo) · Zhong 2022, Nutr Metab (meta-analysis, lipids and glucose)
CC Small or few human trials. Promising, not proven. How we grade →Quercetin Phytosome
Single product (optional) · Healthy inflammatory response
Sub-scores (9/25)
| Human RCTs | 2/5 |
| Effect size | 1/5 |
| Consistency | 1/5 |
| Safety | 2/5 |
| Independence | 3/5 |
Evidence matrix
| Mechanistic | Moderate |
| Animal | Moderate |
| Human observational | Weak |
| Human RCT | Weak |
| Meta-analysis | Weak |
What it is good for: Supporting a healthy inflammatory response.*
What it is not: The largest community trial was essentially null; allergy research is small and used other forms.
Cost per day: $1.53. $46 for 30 days
Worth your money? Optional, not core. Start with the well-supported basics first.
Read the full evidence · Mohammadi-Sartang 2017, Eur J Clin Nutr · Knab 2011, J Am Diet Assoc (1,002 adults, essentially null) · Heinz 2010, Pharmacol Res (same trial, no fewer colds) · Riva 2019, Eur J Drug Metab Pharmacokinet (phytosome absorption, industry-tied) · Andres 2018, Mol Nutr Food Res (safety review) · Kim 2009, Eur J Clin Pharmacol (drug interaction)
BB Good human data, but mixed outcomes or surrogate markers. How we grade →Vitamin D3 2,000 IU (status)
Single product · Maintaining vitamin D status (blood 25(OH)D) in adults with low sun exposure or low intake
Sub-scores (20/25)
| Human RCTs | 5/5 |
| Effect size | 4/5 |
| Consistency | 4/5 |
| Safety | 4/5 |
| Independence | 3/5 |
Evidence matrix
| Mechanistic | Compelling |
| Animal | Weak |
| Human observational | Compelling |
| Human RCT | Compelling |
| Meta-analysis | Compelling |
What it is good for: Raising and maintaining blood 25(OH)D at 2,000 IU a day is very consistent across trials. This grade covers vitamin D status only.
What it is not: The 2024 Endocrine Society guideline advises against routine supplementation above the RDA in generally healthy adults 19 to 74, so this is an intake-gap product, not a routine must-take. No immune, mood, strength or disease claims are made here.
Cost per day: $0.20. $19.90 for 100 softgels (1 a day)
Worth your money? Worth it if your sun exposure or intake is low and your clinician agrees; the multivitamin already gives 400 IU.
Read the full evidence · Ross 2011 (IOM DRI report), J Clin Endocrinol Metab · Demay 2024, J Clin Endocrinol Metab (Endocrine Society guideline) · Sist 2023, Front Nutr (athletes, mixed, no performance claim made) · NIH Office of Dietary Supplements, Vitamin D fact sheet
CC Small or few human trials. Promising, not proven. How we grade →Collagen Peptides
Single product · Skin structure and hydration; joint comfort
Sub-scores (13/25)
| Human RCTs | 3/5 |
| Effect size | 2/5 |
| Consistency | 2/5 |
| Safety | 4/5 |
| Independence | 2/5 |
Evidence matrix
| Mechanistic | Moderate |
| Animal | Moderate |
| Human observational | Weak |
| Human RCT | Moderate |
| Meta-analysis | Moderate |
What it is good for: Trials show small improvements in skin hydration and elasticity with 2.5 to 10 g a day of hydrolyzed collagen peptides over 8 to 12 weeks. Modest, real, and smaller than ads suggest.
What it is not: A 2025 meta-analysis found no skin effect when industry-funded trials were excluded, so the evidence base leans manufacturer-funded. Collagen is also an incomplete protein for muscle: whey or food protein does that job better. No joint-repair claims are made here, and nothing about aging.
Cost per day: $2.14. $29.90 for a 280 g tub (about 14 days at 20 g)
Worth your money? Optional. If you want it anyway, this is an honest C: real but modest evidence, and we publish the caveats on the same page.
Read the full evidence · Myung 2025, Am J Med (meta-analysis; no skin effect excluding industry-funded trials) · de Miranda 2021, Int J Dermatol (meta-analysis, 1,125 participants, skin hydration and elasticity) · Everstack Collagen Peptides label facts (on this page)
CC Small or few human trials. Promising, not proven. How we grade →Magnesium L-threonate
Reviewed, not in a box · Sleep and cognition
Sub-scores (10/25)
| Human RCTs | 1/5 |
| Effect size | 2/5 |
| Consistency | 2/5 |
| Safety | 4/5 |
| Independence | 1/5 |
Evidence matrix
| Mechanistic | Moderate |
| Animal | Compelling |
| Human observational | None |
| Human RCT | Weak |
| Meta-analysis | None |
What it is good for: Interesting rat data and three small trials.
What it is not: All human trials have ties to the ingredient maker; not independently replicated.
Cost per day: Not sold. Glycinate is our magnesium.
Worth your money? Not yet. We chose glycinate at a lower cost.
Read the full evidence · Slutsky 2010, Neuron (rat; brain magnesium and synapses) · Liu 2016, J Alzheimers Dis (12-week RCT; Neurocentria-linked) · Zhang 2022, Nutrients (30-day multi-ingredient RCT) · Hausenblas 2024, Sleep Med X (21-day RCT; AIDP co-authors) · NIH Office of Dietary Supplements, magnesium fact sheet (upper limit 350 mg a day from supplements)
DD Mostly mechanistic or early data. Shown openly. How we grade →Apigenin
Reviewed, not in a box · Sleep and calm
Sub-scores (7/25)
| Human RCTs | 0/5 |
| Effect size | 1/5 |
| Consistency | 1/5 |
| Safety | 3/5 |
| Independence | 2/5 |
Evidence matrix
| Mechanistic | Moderate |
| Animal | Moderate |
| Human observational | None |
| Human RCT | Weak |
| Meta-analysis | Weak |
What it is good for: Chamomile extract trials hint at calm.
What it is not: No published randomized trial of pure apigenin for sleep.
Cost per day: Not sold
Worth your money? No, not at this evidence level.
Read the full evidence · Hieu 2019, Phytother Res (chamomile meta-analysis, 12 RCTs) · Amsterdam 2009, J Clin Psychopharmacol (chamomile RCT, GAD) · Mao 2016, Phytomedicine (chamomile RCT, GAD relapse) · Zick 2011, BMC Complement Altern Med (chamomile RCT, primary insomnia, null) · NCCIH: Chamomile
CC Small or few human trials. Promising, not proven. How we grade →NMN
Reviewed, not sold · Raising NAD+ and insulin sensitivity
Sub-scores (9/25)
| Human RCTs | 2/5 |
| Effect size | 1/5 |
| Consistency | 2/5 |
| Safety | 3/5 |
| Independence | 1/5 |
Evidence matrix
| Mechanistic | Compelling |
| Animal | Compelling |
| Human observational | None |
| Human RCT | Moderate |
| Meta-analysis | Moderate |
What it is good for: It reliably raises blood NAD+ in short trials, and one 10-week trial in 25 women with prediabetes showed better muscle insulin sensitivity.
What it is not: Pooled trials show no clear benefit on blood sugar, lipids or muscle, most trials were industry funded, and there is no human evidence on aging or lifespan.
Cost per day: Not sold
Worth your money? Not yet. We will revisit as trials report.
Read the full evidence · Yoshino 2021, Science (10-week RCT, prediabetes; muscle insulin sensitivity) · Chen 2025, Curr Diab Rep (meta-analysis, glucose and lipids) · Zhang 2025, Crit Rev Food Sci Nutr (meta-analysis with risk-of-bias review) · Prokopidis 2025, J Cachexia Sarcopenia Muscle (meta-analysis, muscle) · Yang 2026, Nutrients (meta-analysis, safety) · Fukamizu 2022, Sci Rep (safety, 1,250 mg a day)
DD Mostly mechanistic or early data. Shown openly. How we grade →Keto BHB salts
Removed from the storefront · Brain energy and cognition
Sub-scores (8/25)
| Human RCTs | 1/5 |
| Effect size | 1/5 |
| Consistency | 1/5 |
| Safety | 3/5 |
| Independence | 2/5 |
Evidence matrix
| Mechanistic | Moderate |
| Animal | Moderate |
| Human observational | None |
| Human RCT | Weak |
| Meta-analysis | None |
What it is good for: Salts modestly raise blood ketones.
What it is not: No long-term trial of salts on cognition; the one we found was null.
Cost per day: Not sold
Worth your money? No. That is why we removed it.
Read the full evidence · Bonnechère 2026, Front Nutr (meta-analysis; salts only 2 studies, 44 people) · Stubbs 2017, Front Physiol · Waldman 2018, Appl Physiol Nutr Metab (salt cognition trial, null) · O'Malley 2017, Appl Physiol Nutr Metab (salt crossover, 10 men; high-intensity cycling worse) · Stefan 2021, Nutrients (90-day salt safety trial, 22 adolescents) · Fortier 2021, Alzheimers Dement (6-month ketogenic MCT drink RCT in MCI; MCT, not salts)
Methodology
We grade each ingredient for its main use, the one on the label, not for the best result in any single study. We read randomized human trials and meta-analyses first, and weight large, long, independently funded trials most. One large null outweighs several small positives.
- AA Multiple randomized trials or meta-analyses, consistent results. How we grade → Strong, consistent randomized human evidence for the main use.
- BB Good human data, but mixed outcomes or surrogate markers. How we grade → Good human evidence with a limitation (dose, population or mixed outcomes).
- CC Small or few human trials. Promising, not proven. How we grade → Promising: human trials are small, short or inconsistent.
- DD Mostly mechanistic or early data. Shown openly. How we grade → Early: mostly mechanism, animal work or a single small trial.
Sub-scores. Five scores from 0 to 5, summed out of 25:
- Human RCTs: Number, size, length and quality of randomized human trials for the main use.
- Effect size: How large and meaningful the average effect is for a typical adult, in absolute terms. A score of 0 means no reliable benefit has been established for the stated use; it does not estimate the true effect as zero.
- Consistency: Whether trials agree, including the largest and best ones.
- Safety: Side effects and drug interactions at the label dose. 5 is very safe; lower means more caution.
- Independence: Share of the evidence from public or independent funding rather than ingredient makers.
Evidence matrix. For each ingredient we show which types of evidence exist and how compelling each is: mechanistic (cell and biochemistry), animal, human observational, human randomized trials and meta-analysis. Mechanism and animal work explain why something might work; only human trials show whether it does in people. That is why the grade rests mostly on the last two columns.
Looking at evidence by study type, and synthesizing several sources rather than relying on any one, is inspired by the approach of Peter Attia, MD. The matrix, scores and wording are ours; he has not reviewed or endorsed Everstack. Source: Peter Attia MD, "A nuanced and multifaceted approach to longevity research", 18 Jan 2025.
We revisit ratings when a relevant trial publishes and at least quarterly. If you spot an error, email us and we will correct it publicly. See also editorial standards · what we leave out.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.